Natural and synthetic inhibitors of the tumor-associated serine protease urokinase-type plasminogen activator

被引：0
|
作者：
Magdolen, V [1 ]
de Prada, NA [1 ]
Sperl, S [1 ]
Muehlenweg, B [1 ]
Luther, T [1 ]
Wilhelm, OG [1 ]
Magdolen, U [1 ]
Graeff, H [1 ]
Reuning, U [1 ]
Schmitt, M [1 ]
机构：
[1] Tech Univ Munich, Klinikum Rechts Isar, Frauenklin, Klin Forschergrp, D-81675 Munich, Germany
来源：
CELLULAR PEPTIDASES IN IMMUNE FUNCTIONS AND DISEASES 2 | 2000年 / 477卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：331 / 341
页数：11
相关论文
共 50 条
  • [1] Inhibitors of the protease domain of urokinase-type plasminogen activator
    Rockway, TW
    Nienaber, V
    Giranda, VL
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2002, 8 (28) : 2541 - 2558
  • [2] Expression of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and plasminogen activator inhibitors in patients with renal cell carcinoma: Correlation with tumor associated macrophage and prognosis
    Ohba, K
    Miyata, Y
    Kanda, S
    Koga, S
    Hayashi, T
    Kanetake, H
    [J]. JOURNAL OF UROLOGY, 2005, 174 (02): : 461 - 465
  • [3] TUMOR-ASSOCIATED UROKINASE-TYPE PLASMINOGEN-ACTIVATOR - BIOLOGICAL AND CLINICAL-SIGNIFICANCE
    SCHMITT, M
    JANICKE, F
    MONIWA, N
    CHUCHOLOWSKI, N
    PACHE, L
    GRAEFF, H
    [J]. BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1992, 373 (07): : 611 - 622
  • [4] Role of Urokinase-Type Plasminogen Activator and Tumor-Associated Trypsinogen in pancreatic cancer metastasis
    Al-Aridhi, Dunia Tahseen Nema
    Hassan, Firas
    Alaridhi, Tania T.
    [J]. JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY, 2023, 30 (01): : E181 - E185
  • [5] Urokinase-type plasminogen activator inhibitors.
    Squires, N
    McGee, D
    Allen, D
    Hruzewicz, W
    Spencer, J
    Sprengeler, P
    Katz, B
    Luong, C
    Mackman, R
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U51 - U51
  • [6] Small molecule inhibitors of urokinase-type plasminogen activator
    Rockway, TW
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2003, 13 (06) : 773 - 786
  • [7] Elucidating novel urokinase-type plasminogen activator inhibitors
    Smith, E.
    Spencer, J.
    Ali, M.
    Abdinejad, M.
    Kankanala, J.
    Fishwick, C.
    Philippou, H.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (06) : E18 - E18
  • [8] Elucidating novel urokinase-type plasminogen activator inhibitors
    Smith, E. L.
    John, S.
    Abdinejad, M.
    Kankanala, J.
    Fishwick, C. W. G.
    Philippou, E.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 819 - 819
  • [9] Hdxms Reveals the Role of Dynamics on the Serine Protease Activity of the Urokinase-Type Plasminogen Activator (UPA)
    Torres-Paris, Constanza
    Xiao, Lufan
    Song, Harriet
    Komives, Elizabeth A.
    [J]. BIOPHYSICAL JOURNAL, 2021, 120 (03) : 100A - 100A
  • [10] Hyperglycemia is associated with lower levels of urokinase-type plasminogen activator and urokinase-type plasminogen activator receptor in wound fluid
    Akinci, Bans
    Terzi, Cem
    Sevindik, Gokmen
    Yuksel, Faize
    Tunc, Ulku Aybuke
    Tunali, Sunay
    Yesil, Sena
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2014, 28 (06) : 844 - 849
12345